Olga Moiseeva

2.7k total citations · 1 hit paper
27 papers, 2.1k citations indexed

About

Olga Moiseeva is a scholar working on Molecular Biology, Physiology and Oncology. According to data from OpenAlex, Olga Moiseeva has authored 27 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Physiology and 6 papers in Oncology. Recurrent topics in Olga Moiseeva's work include Telomeres, Telomerase, and Senescence (8 papers), Microbial bioremediation and biosurfactants (5 papers) and Cancer-related Molecular Pathways (5 papers). Olga Moiseeva is often cited by papers focused on Telomeres, Telomerase, and Senescence (8 papers), Microbial bioremediation and biosurfactants (5 papers) and Cancer-related Molecular Pathways (5 papers). Olga Moiseeva collaborates with scholars based in Canada, Russia and Germany. Olga Moiseeva's co-authors include Gerardo Ferbeyre, Xavier Deschênes‐Simard, Véronique Bourdeau, Michaël Pollak, Frédérick A. Mallette, Sebastian Igelmann, Geneviève Huot, Antoine E. Roux, Marie‐France Gaumont‐Leclerc and Utpal K. Mukhopadhyay and has published in prestigious journals such as Genes & Development, Nature Cell Biology and Molecular and Cellular Biology.

In The Last Decade

Olga Moiseeva

24 papers receiving 2.1k citations

Hit Papers

Metformin inhibits the senescence‐associated secretory ph... 2013 2026 2017 2021 2013 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Olga Moiseeva Canada 17 1.3k 777 356 330 239 27 2.1k
Kimberly J. Krager United States 19 990 0.8× 855 1.1× 362 1.0× 255 0.8× 213 0.9× 42 2.1k
Anand Selvaraj United States 12 1.6k 1.2× 234 0.3× 152 0.4× 288 0.9× 263 1.1× 23 2.3k
Mary L. Hixon United States 21 792 0.6× 279 0.4× 91 0.3× 341 1.0× 245 1.0× 36 1.8k
Hermann Unterluggauer Austria 15 566 0.4× 349 0.4× 146 0.4× 78 0.2× 213 0.9× 19 1.4k
Yasuo Ishida Japan 25 900 0.7× 548 0.7× 436 1.2× 746 2.3× 380 1.6× 112 3.0k
Xavier Deschênes‐Simard Canada 11 1.0k 0.8× 655 0.8× 300 0.8× 368 1.1× 255 1.1× 18 1.8k
Jaskaren Kohli Netherlands 10 755 0.6× 602 0.8× 364 1.0× 220 0.7× 217 0.9× 15 1.6k
Lucilla Luzi Italy 20 2.4k 1.8× 320 0.4× 294 0.8× 408 1.2× 360 1.5× 42 3.1k
Fatouma Alimirah United States 25 851 0.7× 559 0.7× 362 1.0× 296 0.9× 290 1.2× 32 1.9k
Maribel Muñoz‐Martín Spain 10 941 0.7× 807 1.0× 176 0.5× 172 0.5× 211 0.9× 11 1.8k

Countries citing papers authored by Olga Moiseeva

Since Specialization
Citations

This map shows the geographic impact of Olga Moiseeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olga Moiseeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olga Moiseeva more than expected).

Fields of papers citing papers by Olga Moiseeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olga Moiseeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olga Moiseeva. The network helps show where Olga Moiseeva may publish in the future.

Co-authorship network of co-authors of Olga Moiseeva

This figure shows the co-authorship network connecting the top 25 collaborators of Olga Moiseeva. A scholar is included among the top collaborators of Olga Moiseeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olga Moiseeva. Olga Moiseeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luginina, Aleksandra, et al.. (2024). Rational Design of Drugs Targeting G-Protein-Coupled Receptors: A Structural Biology Perspective. Biochemistry (Moscow). 89(4). 747–764.
2.
Moiseeva, Olga, Jordan Guillon, & Gerardo Ferbeyre. (2020). Senescence: A program in the road to cell elimination and cancer. Seminars in Cancer Biology. 81. 48–53. 18 indexed citations
4.
Moiseeva, Olga, et al.. (2020). BIODEGRADATION OF ORGANIC COMPOUNDS.
5.
Lessard, Frédéric, Sebastian Igelmann, Christian Trahan, et al.. (2018). Senescence-associated ribosome biogenesis defects contributes to cell cycle arrest through the Rb pathway. Nature Cell Biology. 20(7). 789–799. 111 indexed citations
6.
Vernier, Mathieu, Lian Mignacca, Frédéric Lessard, et al.. (2016). A CDK4/6-Dependent Epigenetic Mechanism Protects Cancer Cells from PML-induced Senescence. Cancer Research. 76(11). 3252–3264. 48 indexed citations
7.
Moiseeva, Olga, et al.. (2016). VIRAL RECEPTOR GENE EXPRESSION AND MYOCARDITIS DEVELOPMENT. 30(1). 1 indexed citations
8.
Moiseeva, Olga, Stéphane Lopes‐Paciencia, Geneviève Huot, Frédéric Lessard, & Gerardo Ferbeyre. (2016). Permanent farnesylation of lamin A mutants linked to progeria impairs its phosphorylation at serine 22 during interphase. Aging. 8(2). 366–381. 21 indexed citations
9.
Moiseeva, Olga, et al.. (2015). Mutant lamin A links prophase to a p53 independent senescence program. Cell Cycle. 14(15). 2408–2421. 17 indexed citations
10.
Moiseeva, Olga, Xavier Deschênes‐Simard, Sebastian Igelmann, et al.. (2013). Metformin inhibits the senescence‐associated secretory phenotype by interfering with IKK/NF‐κB activation. Aging Cell. 12(3). 489–498. 486 indexed citations breakdown →
11.
Deschênes‐Simard, Xavier, Marie‐France Gaumont‐Leclerc, Véronique Bourdeau, et al.. (2013). Tumor suppressor activity of the ERK/MAPK pathway by promoting selective protein degradation. Genes & Development. 27(8). 900–915. 147 indexed citations
12.
Algire, Carolyn, Olga Moiseeva, Xavier Deschênes‐Simard, et al.. (2012). Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. Cancer Prevention Research. 5(4). 536–543. 288 indexed citations
13.
Vernier, Mathieu, Véronique Bourdeau, Marie‐France Gaumont‐Leclerc, et al.. (2011). Regulation of E2Fs and senescence by PML nuclear bodies. Genes & Development. 25(1). 41–50. 124 indexed citations
14.
Moiseeva, Olga, Véronique Bourdeau, Mathieu Vernier, Marie‐Christine Dabauvalle, & Gerardo Ferbeyre. (2011). Retinoblastoma‐independent regulation of cell proliferation and senescence by the p53–p21 axis in lamin A /C‐depleted cells. Aging Cell. 10(5). 789–797. 30 indexed citations
15.
Mallette, Frédérick A., et al.. (2010). Transcriptome analysis and tumor suppressor requirements of STAT5‐induced senescence. Annals of the New York Academy of Sciences. 1197(1). 142–151. 18 indexed citations
16.
Moiseeva, Olga, Véronique Bourdeau, Antoine E. Roux, Xavier Deschênes‐Simard, & Gerardo Ferbeyre. (2009). Mitochondrial Dysfunction Contributes to Oncogene-Induced Senescence. Molecular and Cellular Biology. 29(16). 4495–4507. 298 indexed citations
17.
Mallette, Frédérick A., et al.. (2004). Human fibroblasts require the Rb family of tumor suppressors, but not p53, for PML-induced senescence. Oncogene. 23(1). 91–99. 74 indexed citations
18.
Solyanikova, Inna P., Olga Moiseeva, Sjef Boeren, et al.. (2003). Conversion of 2-Fluoromuconate tocis-Dienelactone by Purified Enzymes ofRhodococcus opacus1cp. Applied and Environmental Microbiology. 69(9). 5636–5642. 12 indexed citations
19.
Moiseeva, Olga, et al.. (2001). Enzymes of a New Modified ortho-Pathway Utilizing 2-Chlorophenol in Rhodococcus opacus 1CP. Biochemistry (Moscow). 66(5). 548–555. 29 indexed citations
20.
Баскунов, Б. П., et al.. (2000). Dependence of the conversion of chlorophenols by rhodococci on the number and position of chlorine atoms in the aromatic ring. Microbiology. 69(1). 40–47. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026